ABCG2 and colorectal carcinoma: To sum up, our results, for the first time, demonstrate the contribution of TOX3-WDR5-H3K4me3/ABCG2 signaling axis to CRC initiation and development by accelerating stem-like traits and drug resistance evolution (Fig 7F).